Cardiol Therapeutics Inc. Class A Common Shares share price logo

Cardiol Therapeutics Inc. Class A Common Shares

NASDAQ: CRDL

Small Cap

$1.07

+0.01

(+1.42%)

Live

as on

Cardiol Therapeutics Inc. Class A Common Shares Stock Performance

as on June 19, 2026 at 1:15 am IST

  • Day's Low

    $1.04
    $1.07
    downward going graph

    2.80%

    Downside

  • 52 Week's Low

    52 Week's High

    $0.88
    $1.71
    downward going graph

    17.76%

    Downside

    59.81%

    Upside

    downward going graph

Cardiol Therapeutics Inc. Class A Common Shares share price movements today

Previous Close
$1.06
Open
$1.06
Volume
116.8K
Day's Low - High
$1.04 - $1.07
52 Week Low - High
$0.88 - $1.71

Cardiol Therapeutics Inc. Class A Common Shares Historical Returns

1 Month Return
-17.19 %
3 Month Return
+ 7.41 %
1 Year Return
-19.7 %
3 Year Return
+ 9.78 %
5 Year Return
0 %

Cardiol Therapeutics Inc. Class A Common Shares Stock Fundamentals & Key Indicators

Check Cardiol Therapeutics Inc. Class A Common Shares market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$118.7M

EPS (TTM)

-0.36

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-35.6M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-173.96%

Cardiol Therapeutics Inc. Class A Common Shares vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Cardiol Therapeutics Inc. Class A Common Shares with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BUY$118.7MNANA0.00%NA
BUY$23.3B208.96%20.2840.62%NA
HOLD$19.0B10.31%NA-2.04%2.91%
BUY$40.1BNA18.1815.11%2.12%
BUY$33.3B-58.33%1328.04%2.54%

Stock Returns calculator for Cardiol Therapeutics Inc. Class A Common Shares Stock including INR - Dollar returns

The Cardiol Therapeutics Inc. Class A Common Shares stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Cardiol Therapeutics Inc. Class A Common Shares investment value today

Current value as on today

₹88,463

Returns

-₹11,537

(-11.54%)

Returns from Cardiol Therapeutics Inc. Class A Common Shares Stock

-₹18,939 (-18.94%)

Dollar Impact

₹7,403 (+7.4%)

Analyst Recommendation on Cardiol Therapeutics Inc. Class A Common Shares Stock

Based on 8 analysts

BUY

87.50%

Buy

12.50%

Hold

0.00%

Sell

Based on 8 analysts, 87.5% of analysts recommend a 'BUY' rating for Cardiol Therapeutics Inc. Class A Common Shares. Average target price of $7.23

Cardiol Therapeutics Inc. Class A Common Shares Share Price Target

Get share price movements and forecasts by analysts on Cardiol Therapeutics Inc. Class A Common Shares.

What analysts predicted

85.2%UPSIDE

Target Price

$7.23

Current Price

$1.07

Analyzed by

8 Analysts

Target

$7.23

Cardiol Therapeutics Inc. Class A Common Shares target price $7.23, a slight upside of 85.2% compared to current price of $1.07. According to 8 analysts rating.

Indian Investors' Interest in Cardiol Therapeutics Inc. Class A Common Shares Stock

Search interest for Cardiol Therapeutics Inc. Class A Common Shares Stock has decreased by -15% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-15% versus previous 30 day period

Cardiol Therapeutics Inc. Class A Common Shares Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
-
0
0
-
0
-
-
-
0
0
Operating Income
-8
-8
-5
-14
-6
-8
-7
-10
-8
-9
EBITDA
-
-9
-4
-12
-5
-8
-8
-9
-7
-10
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-7
-9
-4
-12
-5
-8
-8
-9
-7
-10
Income Tax Expense
-
0
0
-
-
-
-
-
-
-
Net Income
-5
-6
-3
-9
-3
-5
-8
-9
-7
-10
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Cardiol Therapeutics Inc. Class A Common Shares Annual Profit & Loss

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
0
0
-
-
-
-
Gross Profit
0
0
0
0
0
0
-
-
Operating Income
-7
-10
-16
-30
-30
-22
-40
-34
EBITDA
-7
-10
-16
-24
-22
-21
-36
-33
Interest Expense
0
0
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
Income Before Tax
-15
-10
-16
-25
-22
-21
-36
-33
Income Tax Expense
0
0
0
-6
-10
0
-
-
Net Income
-11
-8
-12
-19
-16
-15
-25
-33
Net Profit Margin
0.00%
0.00%
-20570.94%
-40170.87%
0.00%
0.00%
0.00%
0.00%

Cardiol Therapeutics Inc. Class A Common Shares Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
-9
-6
-12
-8
-8
-8
-9
-7
-10
Operating Cash Flow
-6
-4
-7
-5
-7
-4
-6
-5
-7
Investing Cash Flow
0
0
0
0
0
0
0
0
0
Financing Cash Flow
0
0
0
18
0
0
0
15
13
Change in Cash
-6
-4
-8
14
-7
-5
-6
9
5

Cardiol Therapeutics Inc. Class A Common Shares Annual Cash Flow

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-15
-13
-20
-31
-30
-28
-36
-33
Operating Cash Flow
-10
-11
-9
-23
-27
-25
-25
-23
Investing Cash Flow
0
0
0
0
0
0
0
0
Financing Cash Flow
25
2
16
93
0
0
18
15
Change in Cash
14
-9
7
69
-24
-24
-4
-9

Global Institutional Holdings in Cardiol Therapeutics Inc. Class A Common Shares

Funds
Holdings
Quadrature Capital Limited
0.04%
BOOTHBAY FUND MANAGEMENT, LLC
0.69%
INTEGRITY ALLIANCE, LLC.
0.4%
Atria Investments LLC
0.12%
Virtu Financial LLC
0.13%

Cardiol Therapeutics Inc. Class A Common Shares News & Key Events

  • img

    Today's Timeline - 13 November

    Thu, 06:15 PM

    -

    Cardiol Therapeutics receives U.S. patent allowance for CardiolRx™ and CRD-38, extending protection until late 2040.

Insights on Cardiol Therapeutics Inc. Class A Common Shares

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, CRDL has outperformed top 5 stocks with highest market-cap in its industry

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, SANDOZ GROUP AG SPONSORED ADS Switzerland has given 93.7% return, outperforming this stock by 113.4%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, CRDL stock has moved down by -17.2%

About Cardiol Therapeutics Inc. Class A Common Shares

Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the development of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases. Its lead product candidate is CardiolRx, which is in Phase III multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx in acute myocarditis, as well as for the treatment of recurrent pericarditis. The company is also developing CRD-38, a novel subcutaneously administered drug formulation of cannabidiol for the treatment of heart failure. Cardiol Therapeutics Inc. was incorporated in 2017 and is headquartered in Oakville, Canada.
OrganisationCardiol Therapeutics Inc. Class A Common Shares
Headquarters2265 Upper Middle Road East, Oakville, ON, Canada, L6H 0G5
IndustryDrug Manufacturers - Specialty & Generic
CEOMr. David G. Elsley MBA
E-voting on sharesClick here to vote

Key Management of Cardiol Therapeutics Inc. Class A Common Shares

Name

Title

Mr. Bernard Lim B.Sc.

Chief Operating Officer

Dr. Andrew Warwick Hamer M.D.

Chief Medical Officer and Head of Research & Development

Trevor Burns

Investor Relations

Mr. John A. Geddes BSCPT, MBA

Vice President of Corporate Development

Mr. David G. Elsley MBA

President, CEO & Director

Mr. Christopher J. Waddick C.A., C.M.A., CPA, MBA

CFO, Corporate Secretary & Director

FAQs

What is Cardiol Therapeutics Inc. Class A Common Shares share price today?

Cardiol Therapeutics Inc. Class A Common Shares share price today is $1.07 as on . Cardiol Therapeutics Inc. Class A Common Shares share today touched a day high of $1.07 and a low of $1.04.

What is the 52 week high and 52 week low for Cardiol Therapeutics Inc. Class A Common Shares share?

Cardiol Therapeutics Inc. Class A Common Shares share touched a 52 week high of $1.71 on and a 52 week low of $0.88 on . Cardiol Therapeutics Inc. Class A Common Shares stock price today i.e. is trending at $1.07,which is 37.43% down from its 52 week high and 21.59% up from its 52 week low.

What is Cardiol Therapeutics Inc. Class A Common Shares's market capitalisation today?

Cardiol Therapeutics Inc. Class A Common Shares market capitalisation is $0.00T as on .

How to invest in Cardiol Therapeutics Inc. Class A Common Shares Stock (CRDL) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Cardiol Therapeutics Inc. Class A Common Shares on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Cardiol Therapeutics Inc. Class A Common Shares Shares that will get you 1.4019 shares as per Cardiol Therapeutics Inc. Class A Common Shares share price of $1.07 per share as on June 18, 2026 at 7:45 pm IST.

What is the minimum amount required to buy Cardiol Therapeutics Inc. Class A Common Shares Stock (CRDL) from India?

Indian investors can start investing in Cardiol Therapeutics Inc. Class A Common Shares (CRDL) shares with as little as ₹94.323 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹943.23 in Cardiol Therapeutics Inc. Class A Common Shares stock (as per the Rupee-Dollar exchange rate as on ). Based on Cardiol Therapeutics Inc. Class A Common Shares share’s latest price of $1.07 as on June 18, 2026 at 7:45 pm IST, you will get 9.3458 shares of Cardiol Therapeutics Inc. Class A Common Shares. Learn more about fractional shares .